HGH 191AA (Somatropin) is a recombinant form of human growth hormone (hGH) that is bioidentical to the hormone naturally produced by the pituitary gland.  It plays a key role in regulating growth, metabolism, body composition, and tissue repair. 
Key Health Benefits:
Improved Body Composition: Increases lean body mass and reduces adipose (fat) tissue through enhanced protein synthesis and lipolysis. 
Enhanced Recovery and Tissue Repair: Accelerates healing from injuries and intense workouts by boosting collagen production and cellular regeneration. 
Increased Bone Density: Promotes bone mineralization, reducing fracture risk and supporting joint health. 
Anti-Aging Effects: Improves skin elasticity, reduces wrinkles, and supports hair and nail health by stimulating cell regeneration. 
Metabolic Benefits: Improves lipid profiles, increases exercise capacity, and enhances overall energy levels and mood. 
Supports Muscle Growth: Stimulates the development of lean muscle tissue, particularly when combined with anabolic steroids and insulin. 
Clinical and Research Evidence:
Pivotal studies (e.g., Rudman et al.) showed significant gains in lean mass and reductions in fat mass in older adults with GH deficiency after six months of treatment.
Long-term use in GH-deficient adults demonstrates sustained improvements in muscle strength and body composition.
Benefits are also observed in conditions like HIV-associated wasting, Turner syndrome, Prader-Willi syndrome, and growth hormone deficiency in children. 
Note: While widely used off-label for performance enhancement and anti-aging, HGH 191AA is FDA-approved only for specific medical conditions such as growth hormone deficiency, HIV wasting, and certain genetic disorders.  Off-label use carries health and legal risks, including insulin resistance, joint pain, carpal tunnel syndrome, and potential acceleration of pre-existing conditions like cancer. 
 
FOR RESEARCH USE ONLY.